Australian Study Questions Efficacy Of Bone Cement Treatment
This article was originally published in PharmAsia News
Executive Summary
An Australian study raises serious questions about the efficacy of a popular treatment for osteoporosis. The study conducted by Australian institutions looked into the value of covering percutaneous vertebroplasty under the Medicare Benefits Scheme. The study concluded that after six months of testing the treatment against a placebo treatment, both sets of patients improved by the same degree. The research also raised the possibility the treatment involving injecting bone cement into broken vertebrae might even do more harm than good because of risks involved. (Click here for more